Comparaison de la tolérance et de l’efficacité du biosimilaire de l’infliximab (Remsima®) par rapport au Rémicade® chez les patients atteints de spondyloarthrites
Lamia Oulkadi(Centre Hospitalier Ibn Sina), R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), L. Ichchou(Hôpital El Ayachi), L. Achemlal, N. Jaouad(Hôpital El Ayachi), I. Ghozlani(Régie Autonome Multi Services D'Agadir), Bouchra Amine(Hôpital El Ayachi), H. Hassikou, F. Allali(Délégation Paris 5), I. El Bouchti, Taoufik Harzy(Hôpital El Ayachi), I. Elbinoune(Centre Hospitalier Ibn Sina), Rédouane Abouqal(Mohammed V University), Ihsane Hmamouchi(International University of Rabat), S. Bouayad, O. Mkinsi(Centre Hospitalier Universitaire Ibn Rochd), S. Rostom(Mohammed V University), A. El Maghraoui
Cited by 0
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114